Meta-Analysis
Copyright ©The Author(s) 2022.
World J Clin Cases. Aug 6, 2022; 10(22): 7859-7871
Published online Aug 6, 2022. doi: 10.12998/wjcc.v10.i22.7859
Figure 4
Figure 4 Ranking of treatment strategies based on probability of prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis with the cumulative ranking area. A: Incidence of post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP); B: Mild PEP; C: Moderate-to-severe PEP.